- Home
- PMM vs OSUR Comparison
PMM vs OSUR Comparison
Compare PMM & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMM
- OSUR
- Stock Information
- Founded
- PMM 1989
- OSUR 2000
- Country
- PMM United States
- OSUR United States
- Employees
- PMM N/A
- OSUR N/A
- Industry
- PMM Investment Managers
- OSUR Medical/Dental Instruments
- Sector
- PMM Finance
- OSUR Health Care
- Exchange
- PMM Nasdaq
- OSUR Nasdaq
- Market Cap
- PMM 265.3M
- OSUR 228.1M
- IPO Year
- PMM N/A
- OSUR 1986
- Fundamental
- Price
- PMM $5.78
- OSUR $3.21
- Analyst Decision
- PMM
- OSUR Hold
- Analyst Count
- PMM 0
- OSUR 1
- Target Price
- PMM N/A
- OSUR $3.00
- AVG Volume (30 Days)
- PMM 118.3K
- OSUR 688.0K
- Earning Date
- PMM 01-01-0001
- OSUR 08-05-2025
- Dividend Yield
- PMM 4.68%
- OSUR N/A
- EPS Growth
- PMM N/A
- OSUR N/A
- EPS
- PMM 0.23
- OSUR N/A
- Revenue
- PMM N/A
- OSUR $161,626,000.00
- Revenue This Year
- PMM N/A
- OSUR N/A
- Revenue Next Year
- PMM N/A
- OSUR $6.80
- P/E Ratio
- PMM $26.52
- OSUR N/A
- Revenue Growth
- PMM N/A
- OSUR N/A
- 52 Week Low
- PMM $5.00
- OSUR $2.36
- 52 Week High
- PMM $6.42
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- PMM 35.59
- OSUR 53.13
- Support Level
- PMM $5.77
- OSUR $3.25
- Resistance Level
- PMM $5.86
- OSUR $3.51
- Average True Range (ATR)
- PMM 0.05
- OSUR 0.19
- MACD
- PMM -0.01
- OSUR -0.01
- Stochastic Oscillator
- PMM 5.00
- OSUR 24.69
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.